Can the skin autofluorescence predict retinopathy in diabetes?: Diabet Med von Rigalleau, Vincent, Foussard, N., Larroumet, A., Monlun, M., Blanco, Laurence, Delyfer, Marie Noelle, Korobelnik, Jean-Francois, Mohammedi, Kamel

Volltext

An update to: Pharmacological treatment for type 2 diabetes integrating findings from cardiovascular outcome trials: an expert consensus in the UK. Diabet Med 2019; 36: 1063–1071 von Bain, S. C., Bakhai, A., Evans, M., Green, A., Menown, I., Strain, W. D.

Volltext

Why might pumps fail in pregnant women with Type 1 diabetes?: Diabet Med von Ducos, C., Rigalleau, Vincent, Foussard, N., Cambos, S., Poupon, P., Monlun, M., Blanco, L., Haissaguerre, M., Grouthier, V., Velayoudom-Cephise, F. L., Mohammedi, K.

Volltext

Markers of glycation and neonatal hypoglycaemia in gestational diabetes mellitus: Diabet Med von Foussard, N., Baillet-Blanco, L., Poupon, P., Monlun, M., Mohammedi, K., Cougnard-Gregoire, Audrey, Delcourt, Cecile, Helmer, Catherine, Rigalleau, Vincent

Volltext

Nerve action potential amplitudes, a robust marker of diabetic peripheral neuropathy: Diabet Med von Monlun, M., Hugo, M., Blanco, L., Mohammedi, K., Ahdab, R., Alexandre, L., Poirot-Mazeres, S., Rajaobelina, Kalina, Rigalleau, Vincent

Volltext

Predictors of early renal function decline in Type 1 diabetes: retinopathy: Diabet Med von Monlun, M., Blanco, L., Alexandre, L., Mohammedi, K., Rigalleau, Vincent

Volltext

Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study: Diabet Med von Dybjer, E., Engstrom, G., Helmer, Catherine, Nagga, K., Rorsman, P., Nilsson, P. M.

Volltext

Carlton J, Powell P, Rowen D, Broadley M, Pouwer F, Speight J, Heller S, Gall MA, Rosilio M, Child CJ, Comins J, McCrimmon RJ, de Galan B, Brazier J ; Hypo‐RESOLVE CONSORTIUM . Producing a preference‐based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: a mixed‐methods research protocol . Diabet Med 2023 Mar; 40 ( 3 ): e15007 . doi: 10.1111/dme.15007

Volltext

Reply to Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009; 26: 474-477 von Andrews, J.

Volltext

der Ven NC, Hogenelst MH, Tromp-Wever AM, Twisk JW, der Ploeg HM, Heine RJ, Snoek FJ: Short-term effects of cognitive behavioural group training in adult type 1 diabetes patients in prolonged poor glycaemic control: a randomized controlled trial. Diabet Med 22:1619-1623, 2005 von Fonseca, Vivian

Volltext

Erratum: Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 1998; 15(1): 15-24 von Hattersley, A T

Volltext

Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs von Hex, N., Bartlett, C., Wright, D., Taylor, M., Varley, D.

Volltext

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications... von Herman, W. H., Pop-Busui, R., Braffett, B. H., Martin, C. L., Cleary, P. A., Albers, J. W., Feldman, E. L.

Volltext

Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review von Buckley, B. S., Harreiter, J., Damm, P., Corcoy, R., Chico, A., Simmons, D., Vellinga, A., Dunne, F.

Volltext

Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study von Orchard, T. J., Temprosa, M., Barrett-Connor, E., Fowler, S. E., Goldberg, R. B., Mather, K. J., Marcovina, S. M., Montez, M., Ratner, R. E., Saudek, C. D., Sherif, H., Watson, K. E.

Volltext

Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis von George, P. S., Pearson, E. R., Witham, M. D.

Volltext

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological a... von Hotta, N., Kawamori, R., Fukuda, M., Shigeta, Y.

Volltext

Dorothy Hodgkin Lecture 2012 Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management von Byrne, C. D.

Volltext

Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis von Savage, M. W., Dhatariya, K. K., Kilvert, A., Rayman, G., Rees, J. A. E., Courtney, C. H., Hilton, L., Dyer, P. H., Hamersley, M. S.

Volltext

A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy von Papanas, N., Boulton, A. J. M., Malik, R. A., Manes, C., Schnell, O., Spallone, V., Tentolouris, N., Tesfaye, S., Valensi, P., Ziegler, D., Kempler, P.

Volltext